tiprankstipranks
Trending News
More News >
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Stock Investors

Compare
577 Followers
Based on 794,749 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VERV
On average, investors allocate 2.49% of their portfolios to VERV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 794,749 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VERV

2.1%
Last 7
Days
6.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VERV, out of 794,749 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VERV Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.35%
$7.61
Increased
2.19%
$7.03
Based on the activity of investors who made their portfolios public
The table shows changes in VERV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VERV Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
UiPath
3.32%
-0.68%
-1.01%
5.54B
Technology
Lucid Group
5.47%
-0.29%
+1.78%
7.43B
Consumer Cyclical
Block
3.67%
-0.13%
+4.05%
31.27B
Technology
JD
4.94%
-1.74%
+0.54%
51.75B
Consumer Cyclical
Recursion Pharmaceuticals
3.19%
-1.07%
-2.47%
1.69B
Healthcare
Nio
8.81%
-0.76%
-0.64%
6.54B
Consumer Cyclical
Fortinet
3.57%
+0.42%
+0.56%
67.67B
Technology
Intuitive Surgical
3.59%
-0.16%
+3.48%
166.10B
Healthcare
Trade Desk
3.31%
+0.48%
+9.98%
22.99B
Technology
Zscaler
3.47%
-0.19%
+0.09%
27.86B
Technology
Based on the activity of 794,749 active portfolios
Open your Smart Portfolio

VERV Investor Analysis

VERV investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.0%
of VERV holders
are under 35
Average Segment Performance
Average P/E Ratio16.83
Beta5.56
Dividend Yield4.09%
VERV investors between 35–55

Between 35–55

2.3%
Last 30 days
Holdings Change
53.0%
of VERV holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.92
Beta13.64
Dividend Yield3.58%
VERV investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.0%
of VERV holders
are over 55
Average Segment Performance
Average P/E Ratio13.94
Beta8.07
Dividend Yield3.86%
Overview of age group and performance of VERV stock investors
See who invests in VERV according to age group and performance.

FAQ

How many retail Investors hold VERV?
<0.1% of TipRanks' retail investors hold VERV in their portfolios.
    What is VERV Investor Sentiment?
    VERV’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of VERV in the last 7 days?
      ▼ 2.1% of TipRanks' retail investors changed their holding of VERV in the last 7 days.
        What percentage of retail investors changed their holding of VERV in the last 30 days?
        ▼ 6.5% of TipRanks' retail investors changed their holding of VERV in the last 30 days.
          What is the average age of retail investors who hold VERV?
          The average age of VERV Holders is between 35–55.
            What other stocks have VERV investors also bought?
            VERV Investors also bought PATH, LCID, XYZ, JD, RXRX, NIO, FTNT, ISRG, TTD, ZS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              CORCencora
              BSXBoston Scientific
              CNCCentene
              GSKGlaxoSmithKline
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis